Clinical Trials on Tube Feeding

Total 4474 results

Fred Hutchinson Cancer Center

Completed

Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Pfizer

Completed

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

United States, Canada
The University of Tennessee, Knoxville

Active, not recruiting

Lowering Caloric Density of the Diet (Lower CD)

Obesity | Feeding Behavior

United States
University Hospitals Cleveland Medical Center

Withdrawn

Intrapartum Epidural Fentanyl and Breast-feeding in the Immediate Postpartum Period: a Prospective Cohort Study

Breast Feeding | Fentanyl | Nalbuphine | Maternal Anaesthesia and Analgesia Affecting Fetus or Newborn | Bupivacaine

United States
Ana Maria Linares

Completed

Childhood Risk Reduction Program in Hispanics (ECOR-H)

Breast Feeding, Exclusive
University of California, San Francisco

Completed

Using the Electronic Health Record to Guide Management of Newborn Weight Loss

Breastfeeding | Breastfeeding, Exclusive | Feeding, Bottle | Morbidity;Perinatal

United States
Mercy Health System
Rockford Memorial Hospital Development Foundation

Terminated

The Effects of Probiotic Supplementation on Extremely Low Birthweight Infants

Feeding Tolerance

United States
Seattle Institute for Biomedical and Clinical Research
American College of Gastroenterology

Completed

The Effects of Mindfulness Training on Eating Behaviors and Food Intake

Obesity | Feeding Behavior
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Stage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IV Fallopian Tube Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IV Primary Peritoneal Cancer AJCC v8 | Stage II Fallopian Tube Cancer AJCC v8 | Stage II Ovarian... and other conditions

United States, Canada, Korea, Republic of, Puerto Rico, Ireland
National Human Genome Research Institute (NHGRI)

Terminated

Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population

Hereditary Oral Clefts | Neural Tube Defects (NTDs) | Facial Cleft Defect

United States
Sultan Abdulhamid Han Training and Research Hospital...

Recruiting

Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age (CANFRADE)

Cancer | Death | Frailty | Rumination

Turkey
Université Catholique de Louvain

Completed

A Cognitive-behavioral Intervention of Rumination for Perfectionists

Depression | Anxiety | Perfectionism | Rumination - Thoughts

Belgium
Istanbul University - Cerrahpasa (IUC)

Completed

Turkish Cultural Adaptation, Validity and Reliability of the "Physical Activity-Specific Rumination Scale for Children"

Physical Activity | Children, Only | Rumination

Turkey
East Tennessee State University

Withdrawn

Use of Prokinetics in Early Enteral Feeding in Preterm Infants

Feeding Disorder | Infant,Premature | Nutrition Disorder

United States
Imunon
Break Through Cancer Foundation

Recruiting

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer (MRD)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
Shanghai Gynecologic Oncology Group
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Obstetrics... and other collaborators

Not yet recruiting

Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma

China
Green3Bio, Inc.

Suspended

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

Ovarian Tumors

United States
Hoffmann-La Roche

Completed

A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

China
H. Lee Moffitt Cancer Center and Research Institute
The V Foundation for Cancer Research; Kay Yow Cancer Fund

Completed

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

Peritoneal Diseases | Ovarian Diseases | Fallopian Tube Diseases | Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
Ronald Buckanovich

Completed

Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Carcinoma

United States
Jason D. Wright
Genentech, Inc.

Completed

Neoadjuvant Therapy for Ovarian Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

United States
ImmunoGen, Inc.
Gynecologic Oncology Group

Completed

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer (FORWARD I)

Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Carcinoma

United States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
Royal Surrey County Hospital NHS Foundation Trust

Unknown

Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival (MIRRORS)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Neoplasm | Ovarian Neoplasm Epithelial

United Kingdom
Abramson Cancer Center of the University of Pennsylvania
Ovarian Cancer Research Center

Terminated

Autologous OC-L Vaccine and Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Primary Ovarian Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Merck Sharp & Dohme LLC; Brigham and Women's...

Terminated

Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
The University of Texas Health Science Center at...

Completed

A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer (ONTAK)

Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Extraovarian Peritoneal Cancer

United States
Masonic Cancer Center, University of Minnesota

Terminated

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Centre Francois Baclesse

Completed

Search for Predictors of Therapeutic Response in Ovarian Carcinoma (miRSa)

Fallopian Tube Cancer | Carcinoma of the Ovary | Peritoneal Serous-type Advanced Stage

France
NYU Langone Health
Genentech, Inc.

Completed

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

United States
Women and Infants Hospital of Rhode Island
Amgen

Terminated

Panitumumab and Gemcitabine in Relapsed Ovarian Cancer (PanGem)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

United States
Medical Research Council
European Organisation for Research and Treatment of Cancer - EORTC

Completed

Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Spain, Belgium, France, Netherlands, Austria, United Kingdom, Italy, South Africa, Portugal, Ireland
AstraZeneca

Completed

ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Precision Therapeutics

Terminated

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer

United States
M.D. Anderson Cancer Center
Bristol-Myers Squibb; InterMune; Bayer Healthcare Pharmaceuticals, Inc./Bayer...

Completed

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
AGO Study Group

Completed

A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy

Ovarian Cancer | Peritoneal Cancer | Cancer of the Fallopian Tube

Germany
Vanderbilt University Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing (MOTHER SEED)

Cesarean Section | Microbiome | Vaginal Seeding | Nose

United States
University of Calgary

Recruiting

Efficacy of Balloon Dilation of the Eustachian Tube in Eustachian Tube Dilatory Dysfunction

Eustachian Tube Dysfunction | Barotitis

Canada
Cairo University

Completed

Hysteroscopic Versus Laparoscopic Tubal Occlusion in Cases of Hydrosalpinx and Planning for IVF

Tubal Obstruction

Egypt
Chiayi Christian Hospital

Completed

Cold Application on Pain During Chest Tube Removal

Chest Tube Removal
Haukeland University Hospital
Helse Fonna

Recruiting

A Digital Treatment for Adolescents With Eating Disorders

Eating Disorders

Norway
Oslo University Hospital
University of Oslo; University Hospital of North Norway; University of California... and other collaborators

Recruiting

Comparing Enhanced Cognitive-behavior Therapy and Family-based Treatment for Adolescents With an Eating Disorder (CogFam)

Feeding and Eating Disorders

Norway
University of Barcelona
University of Burgos

Recruiting

Online Prevention Program for Eating Disorders Applied to College Students. Spanish Validation of the eBodyProject

Eating Disorders

Spain
IRCCS Burlo Garofolo

Recruiting

Oral Lesions in Patients With Eating Disorders

Eating Disorders

Italy
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

Treatment Uptake Chatbot for Eating Disorders

Eating Disorders

United States
Amasya University

Completed

The Effect of Education Given to Postpartum Women on Their Attitudes Towards Childhood Vaccinations and Breastfeeding

Breast Feeding | Vaccination Refusal | Training Group, Sensitivity

Turkey
Stanford University
National Institute of Mental Health (NIMH)

Completed

Reducing Eating Disorder Risk Factors

Eating Disorders

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH); Stanford University

Completed

Using Technology to Improve Eating Disorders Treatment

Eating Disorders

Clinical Trials on Tube Feeding

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations